-
1
-
-
0020961939
-
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
-
F.R. Rickles, and R.L. Edwards Activation of blood coagulation in cancer: Trousseau's syndrome revisited Blood 62 1983 14 31
-
(1983)
Blood
, vol.62
, pp. 14-31
-
-
Rickles, F.R.1
Edwards, R.L.2
-
3
-
-
0021951262
-
Cerebrovascular complications in patients with cancer
-
F. Graus, L.R. Rogers, and J.B. Posner Cerebrovascular complications in patients with cancer Medicine 64 1985 16 35
-
(1985)
Medicine
, vol.64
, pp. 16-35
-
-
Graus, F.1
Rogers, L.R.2
Posner, J.B.3
-
4
-
-
2942627941
-
Stroke in patients with cancer: Incidence and etiology
-
D.M. Cestari, D.M. Weine, and K.S. Panageas et al. Stroke in patients with cancer: incidence and etiology Neurology 62 2004 2025 2030
-
(2004)
Neurology
, vol.62
, pp. 2025-2030
-
-
Cestari, D.M.1
Weine, D.M.2
Panageas, K.S.3
-
6
-
-
22844442721
-
Hypercoagulable states and stroke: A selective review
-
S.R. Levine Hypercoagulable states and stroke: a selective review CNS Spectrums 10 2005 567 578
-
(2005)
CNS Spectrums
, vol.10
, pp. 567-578
-
-
Levine, S.R.1
-
7
-
-
0037775639
-
Cancer-associated thrombosis
-
R.L. Bick Cancer-associated thrombosis New Engl J Med 349 2003 109 111
-
(2003)
New Engl J Med
, vol.349
, pp. 109-111
-
-
Bick, R.L.1
-
8
-
-
33846913898
-
Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: A nested case-control study
-
Y.Y. Zhang, D. Cordato, and Q. Shen et al. Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study Cerebrovasc Dis 23 2007 181 187
-
(2007)
Cerebrovasc Dis
, vol.23
, pp. 181-187
-
-
Zhang, Y.Y.1
Cordato, D.2
Shen, Q.3
-
9
-
-
0028952464
-
Interrater reliability of an etiologic classification of ischemic stroke
-
C.J. Johnson, S.J. Kittner, and R.J. McCarter et al. Interrater reliability of an etiologic classification of ischemic stroke Stroke 26 1995 46 51
-
(1995)
Stroke
, vol.26
, pp. 46-51
-
-
Johnson, C.J.1
Kittner, S.J.2
McCarter, R.J.3
-
10
-
-
0027514354
-
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment
-
H.P. Adams Jr., B.H. Bendixen, and L.J. Kappelle et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment Stroke 24 1993 35 41
-
(1993)
Stroke
, vol.24
, pp. 35-41
-
-
Adams Jr., H.P.1
Bendixen, B.H.2
Kappelle, L.J.3
-
11
-
-
0028261221
-
Should cerebral ichemic events be considered a manifestation of hypercoagulability?
-
S. Chaturvedi Should cerebral ichemic events be considered a manifestation of hypercoagulability? Stroke 25 1994 1215 1218
-
(1994)
Stroke
, vol.25
, pp. 1215-1218
-
-
Chaturvedi, S.1
-
12
-
-
84862794927
-
Cancer-associated ischemic stroke is associated with elevated d-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer
-
T. Kono Cancer-associated ischemic stroke is associated with elevated d-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer Geriatr Gerontol Int 12 2012 468 474
-
(2012)
Geriatr Gerontol Int
, vol.12
, pp. 468-474
-
-
Kono, T.1
-
13
-
-
33750609827
-
Stroke risk factor, pattern and outcome in patients with cancer
-
Y.Y. Zhang, D.K. Chan, and D. Cordato et al. Stroke risk factor, pattern and outcome in patients with cancer Acta Neurologic Scand 114 2006 378 383
-
(2006)
Acta Neurologic Scand
, vol.114
, pp. 378-383
-
-
Zhang, Y.Y.1
Chan, D.K.2
Cordato, D.3
-
16
-
-
70349398317
-
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: A randomised, placebo-controlled, double-blind study
-
G. Agnelli, G. Gussoni, and C. Bianchini et al. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study Lancet Oncol 10 2009 943 949
-
(2009)
Lancet Oncol
, vol.10
, pp. 943-949
-
-
Agnelli, G.1
Gussoni, G.2
Bianchini, C.3
-
17
-
-
0037960145
-
Cerebral ischemic events and anti-cancer therapy
-
M. El Amrani, S. Aidi, and P. Amarenco Cerebral ischemic events and anti-cancer therapy Rev Neurol 159 2003 371 380
-
(2003)
Rev Neurol
, vol.159
, pp. 371-380
-
-
El Amrani, M.1
Aidi, S.2
Amarenco, P.3
-
18
-
-
0031659621
-
Acute stroke following cisplatin therapy
-
G.E. Gamble, and P. Tyrrell Acute stroke following cisplatin therapy Clin Oncol 10 1998 274 275
-
(1998)
Clin Oncol
, vol.10
, pp. 274-275
-
-
Gamble, G.E.1
Tyrrell, P.2
-
19
-
-
33846107194
-
Risk of ischemic stroke and lifetime estrogen exposure
-
M.A. de Lecinana, J.A. Egido, and C. Fernandez et al. Risk of ischemic stroke and lifetime estrogen exposure Neurology 68 2007 33 38
-
(2007)
Neurology
, vol.68
, pp. 33-38
-
-
De Lecinana, M.A.1
Egido, J.A.2
Fernandez, C.3
-
20
-
-
33645859308
-
Association between plasma levels of d-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders
-
R.N. Moresco, R.H. Junior, and L. Claudio Rosa Vargas et al. Association between plasma levels of d-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders J Thromb Thrombolys 21 2006 199 202
-
(2006)
J Thromb Thrombolys
, vol.21
, pp. 199-202
-
-
Moresco, R.N.1
Junior, R.H.2
Claudio Rosa Vargas, L.3
|